|
1
|
de Rooij NK, Linn FH, van der Plas JA,
Algra A and Rinkel GJ: Incidence of subarachnoid haemorrhage: A
systematic review with emphasis on region, age, gender and time
trends. J Neurol Neurosurg Psychiatry. 78:1365–1372. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bederson JB, Connolly ES Jr, Batjer HH,
Dacey RG, Dion JE, Diringer MN, Duldner JE Jr, Harbaugh RE, Patel
AB and Rosenwasser RH: American Heart Association: Guidelines for
the management of aneurysmal subarachnoid hemorrhage: A statement
for healthcare professionals from a special writing group of the
stroke council, American heart association. Stroke. 40:994–1025.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cossu G, Messerer M, Oddo M and Daniel RT:
To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.
Biomed Res Int. 2014:6285972014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mascia L, Fedorko L, Stewart DJ, Mohamed
F, terBrugge K, Ranieri VM and Wallace MC: Temporal relationship
between endothelin-1 concentrations and cerebral vasospasm in
patients with aneurysmal subarachnoid hemorrhage. Stroke.
32:1185–1190. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cao L, Xu CB, Zhang Y, Cao YX and
Edvinsson L: Secondhand smoke exposure induces
Raf/ERK/MAPK-mediated upregulation of cerebrovascular endothelin
ETA receptors. BMC Neurosci. 12:1092011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie A, Aihara Y, Bouryi VA, Nikitina E,
Jahromi BS, Zhang ZD, Takahashi M and Macdonald RL: Novel mechanism
of endothelin-1-induced vasospasm after subarachnoid hemorrhage. J
Cereb Blood Flow Metab. 27:1692–1701. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zubkov AY, Rollins KS, Parent AD, Zhang J
and Bryan RM Jr: Mechanism of endothelin-1-induced contraction in
rabbit basilar artery. Stroke. 31:526–533. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hino A, Tokuyama Y, Kobayashi M, Yano M,
Weir B, Takeda J, Wang X, Bell GI and Macdonald RL: Increased
expression of endothelin B receptor mRNA following subarachnoid
hemorrhage in monkeys. J Cereb Blood Flow Metab. 16:688–697. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Itoh S, Sasaki T, Asai A and Kuchino Y:
Prevention of delayed vasospasm by an endothelin ETA receptor
antagonist, BQ-123: Change of ETA receptor mRNA expression in a
canine subarachnoid hemorrhage model. J Neurosurg. 81:759–764.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zuccarello M, Boccaletti R, Romano A and
Rapoport RM: Endothelin B receptor antagonists attenuate
subarachnoid hemorrhage-induced cerebral vasospasm. Stroke.
29:1924–1929. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kikkawa Y, Matsuo S, Kameda K, Hirano M,
Nakamizo A, Sasaki T and Hirano K: Mechanisms underlying
potentiation of endothelin-1-induced myofilament Ca(2+)
sensitization after subarachnoid hemorrhage. J Cereb Blood Flow
Metab. 32:341–352. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Assenzio B, Martin EL, Stankevicius E,
Civiletti F, Fontanella M, Boccaletti R, Berardino M, Mazzeo A,
Ducati A, Simonsen U and Mascia L: Cerebrospinal fluid from
patients with subarachnoid haemorrhage and vasospasm enhances
endothelin contraction in rat cerebral arteries. PLoS One.
10:e01164562015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ogungbo B: The world federation of
neurological surgeons scale for subarachnoid hemorrhage. Surg
Neurol. 59:236–238. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fisher CM, Kistler JP and Davis JM:
Relation of cerebral vasospasm to subarachnoid hemorrhage
visualized by computerized tomographic scanning. Neurosurgery.
6:1–9. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bacigaluppi S, Zona G, Secci F, Spena G,
Mavilio N, Brusa G, Agid R, Krings T, Ottonello G and Fontanella M:
Diagnosis of cerebral vasospasm and risk of delayed cerebral
ischemia related to aneurysmal subarachnoid haemorrhage: An
overview of available tools. Neurosurg Rev. 38:603–618. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mehta V, Russin J, Spirtos A, He S,
Adamczyk P, Amar AP and Mack WJ: Matrix metalloproteinases in
cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Neurol Res Int. 2013:9437612013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tuttolomondo A, Di Sciacca R, Di Raimondo
D, Pedone C, La Placa S, Pinto A and Licata G: Effects of clinical
and laboratory variables and of pretreatment with cardiovascular
drugs in acute ischaemic stroke: A retrospective chart review from
the GIFA study. Int J Cardiol. 151:318–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tuttolomondo A, Pecoraro R, Casuccio A, Di
Raimondo D, Buttà C, Clemente G, Della Corte V, Guggino G, Arnao V,
Maida C, et al: Peripheral frequency of CD4+ CD28- cells in acute
ischemic stroke: Relationship with stroke subtype and severity
markers. Medicine (Baltimore). 94:e8132015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barton M: The discovery of
endothelium-dependent contraction: The legacy of Paul M. Vanhoutte.
Pharmacol Res. 63:455–462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kessler IM, Pacheco YG, Lozzi SP, de
Araújo AS Jr, Onishi FJ and de Mello PA: Endothelin-1 levels in
plasma and cerebrospinal fluid of patients with cerebral vasospasm
after aneurysmal subarachnoid hemorrhage. Surg Neurol. 64 Suppl
1:S1:2–5; discussion S1:5. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peterson JW, Kwun BD, Teramura A, Hackett
JD, Morgan JA, Nishizawa S, Bun T and Zervas NT: Immunological
reaction against the aging human subarachnoid erythrocyte. A model
for the onset of cerebral vasospasm after subarachnoid hemorrhage.
J Neurosurg. 71:718–726. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Suzuki R, Masaoka H, Hirata Y, Marumo F,
Isotani E and Hirakawa K: The role of endothelin-1 in the origin of
cerebral vasospasm in patients with aneurysmal subarachnoid
hemorrhage. J Neurosurg. 77:96–100. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang KC, Tang SC, Lee JE, Lai DM, Huang
SJ, Hsieh ST, Jeng JS and Tu YK: Prognostic value of intrathecal
heme oxygenase-1 concentration in patients with Fisher Grade III
aneurysmal subarachnoid hemorrhage. J Neurosurg. 121:1388–1393.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kolias AG, Sen J and Belli A: Pathogenesis
of cerebral vasospasm following aneurysmal subarachnoid hemorrhage:
Putative mechanisms and novel approaches. J Neurosci Res. 87:1–11.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cao L, Ping NN, Cao YX, Li W, Cai Y,
Warfvinge K and Edvinsson L: The effects of MEK1/2 inhibition on
cigarette smoke exposure-induced ET receptor upregulation in rat
cerebral arteries. Toxicol Appl Pharmacol. 304:70–78. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Onoue H, Kaito N, Akiyama M, Tomii M,
Tokudome S and Abe T: Altered reactivity of human cerebral arteries
after subarachnoid hemorrhage. J Neurosurg. 83:510–515. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Tian Y, Wang D, Wei H, Zhao Z,
Jiang R, Yue S and Zhang J: High Angiopoietin-1 levels predict a
good functional outcome within 72 h of an aneurysmal subarachnoid
hemorrhage: A prospective study from a single center. J Neurol Sci.
356:72–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zuccarello M, Lewis AI and Rapoport RM:
Endothelin ETA and ETB receptors in subarachnoid hemorrhage-induced
cerebral vasospasm. Eur J Pharmacol. 259:R1–R2. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Clozel M, Gray GA, Breu V, Löffler BM and
Osterwalder R: The endothelin ETB receptor mediates both
vasodilation and vasoconstriction in vivo. Biochem Biophys Res
Commun. 186:867–873. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hansen-Schwartz J, Hoel NL, Zhou M, Xu CB,
Svendgaard NA and Edvinsson L: Subarachnoid hemorrhage enhances
endothelin receptor expression and function in rat cerebral
arteries. Neurosurgery. 52:1188–1194. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Macdonald RL, Kassell NF, Mayer S,
Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S and Pasqualin
A: CONSCIOUS-1 Investigators: Clazosentan to overcome neurological
ischemia and infarction occurring after subarachnoid hemorrhage
(CONSCIOUS-1): Randomized, double-blind, placebo-controlled phase 2
dose-finding trial. Stroke. 39:3015–3021. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Macdonald RL, Higashida RT, Keller E,
Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A,
et al: Randomised trial of clazosentan, an endothelin receptor
antagonist, in patients with aneurysmal subarachnoid hemorrhage
undergoing surgical clipping (CONSCIOUS-2). Acta Neurochir Suppl.
115:27–31. 2013.PubMed/NCBI
|
|
34
|
Macdonald RL, Higashida RT, Keller E,
Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A,
et al: Randomized trial of clazosentan in patients with aneurysmal
subarachnoid hemorrhage undergoing endovascular coiling. Stroke.
43:1463–1469. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suzuki H, Hasegawa Y, Kanamaru K and Zhang
JH: Mitogen-activated protein kinases in cerebral vasospasm after
subarachnoid hemorrhage: A review. Acta Neurochir Suppl.
110:133–139. 2011.PubMed/NCBI
|
|
36
|
Chen QW, Edvinsson L and Xu CB: Role of
ERK/MAPK in endothelin receptor signaling in human aortic smooth
muscle cells. BMC Cell Biol. 10:522009. View Article : Google Scholar : PubMed/NCBI
|
